![]() |
||||||
LOW | HIGH |
High | |||
Medium | |||
Low | |||
Short | Int | Long |
Seeks to provide current income while maintaining limited price volatility.
The fund invests in a variety of high-quality and, to a lesser extent, medium-quality fixed income securities, at least 80% of which will be short- and intermediate-term investment-grade securities. High-quality fixed income securities are those rated the equivalent of A3 or better by Moody‘s Investors Service, Inc., or another independent rating agency or, if unrated, are determined to be of comparable quality by the fund’s advisor; medium-quality fixed income securities are those rated the equivalent of Baa1, Baa2, or Baa3 by Moody‘s or another independent rating agency or, if unrated, are determined to be of comparable quality by the fund’s advisor. (Investment-grade fixed income securities are those rated the equivalent of Baa3 and above by Moody’s or another independent rating agency or, if unrated, are determined to be of comparable quality by the fund’s advisor.) The fund is expected to maintain a dollar-weighted average maturity of 1 to 4 years.
Performance** | 1 Year | 3 Year | 5 Year | 10 Year | ||
---|---|---|---|---|---|---|
Fund | Vanguard Short-Term Investment-Grade Fund | 6.45% | 3.68% | 2.69% | 2.37% | |
Index | Bloomberg Barclays Credit 1-5 Year Indexi175 | 6.26% | 3.51% | 2.50% | 2.36% | |
Peer Group | Morningstar Short-Term Bond Peer Groupp51 | 5.91% | 3.41% | 2.70% | 2.07% |
Expense Ratio (as of 3-31-25)**** | ||||
---|---|---|---|---|
Expense Ratio**** | 0.09% | Cost Per $1,000 | $0.90 |
Overall Morningstar Rating™: | ★★★★ |
Overall # of Funds in Category: | 529 |
Morningstar Category6A: | Short-Term Bond |
No. of funds: | 3yr 529; 5yr 485; 10yr 365 |
The Overall Morningstar Rating™ for the underlying fund is derived from a weighted average of the performance figures associated with its three-, five- and 10-year (if applicable) Morningstar Rating™ metrics. The rating formula most heavily weights the three year rating, using the following calculation: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. Rating does not include the effects of sales charges, loads, and redemption fees. Past performance does not guarantee future results. Ratings are as follows: 3yr=3; 5yr=3; 10yr=4. See Important Notes for the rating criteria. |
Top Holdings (as of 01-31-25)¤ | |
---|---|
United States Treasury Notes | 1.2% |
AbbVie Inc. | 0.7% |
AbbVie Inc. | 0.7% |
The Boeing Company | 0.7% |
United States Treasury Notes | 0.6% |
Pfizer Investment Enterprises Pte Ltd. | 0.6% |
United States Treasury Notes | 0.5% |
United States Treasury Notes | 0.4% |
United States Treasury Notes | 0.4% |
United States Treasury Notes | 0.4% |
Totals 6.2% of assets |
Number of Holdings | 2030 |
Beta | 1.02 (Bloomberg Credit 1-5 Yr TR USD) |
R² | 99.75 (Bloomberg Credit 1-5 Yr TR USD) |
Effective Duration | 2.58 |
YTM (Yield to Maturity) | 5.02 |
Average Credit QualityG | BBB |
Turnover (annualized)§ | 70.00 |
Net Assets | $55.5 billion |
Underlying fund expense ratios | • Gross* 0.09% • Net* 0.09% |
Effective Maturity | 2.90 |
GT-P2459-VSI 05/25